Table 1.
Demographic and Clinical Characteristics of the Study Participants
| Non-Responders (n = 6) | Responders (n = 6) | Statistical Analysis, p-value | |
|---|---|---|---|
| Age at baseline (mean ± SD) | 13.3 ± 2.1 | 11.8 ± 3.1 | U = 13.5, p = 0.485 |
| Gender (female) (n, %) | 3/6 (50.0%) | 3/6 (50.0%) | X27 = 0.0, p = 1.0 |
| Family history of psychiatric disease (n, %) | 5/6 (83.3%) | 5/6 (83.3%) | X21 = 0.0, p = 1.0 |
| Family history of OCD (n, %) | 2/6 (33.3%) | 1/6 (16.6%) | X21 = 0.0, p = 1.0 |
| Comorbid diagnoses (n, %) | 6/6 (100.0%) | 3/6 (50.0%) | X21 = 4.0, p = 0.182 |
| Anxiety disorders (n, %) | 5/6 (83.3%) | 0/6 (0.0%) | |
| Simple phobia (n, %) | 0/6 (0.0%) | 1/6 (16.6%) | |
| Anorexia nervosa (n, %) | 0/6 (0.0%) | 1/6 (16.6%) | |
| ADHD (n, %) | 0/6 (0.0%) | 1/6 (16.6%) | |
| Oppositional defiant disorder (n, %) | 1/6 (16.6%) | 0/6 (0.0%) | |
| CYBOCS at baseline (mean ± SD) | 21.3 ± 7.0 | 19.8 ± 4.0 | U = 13.5, p = 0.485 |
| CYBOCS at follow-up (mean ± SD) | 19.3 ± 6.1 | 9.8 ± 2.8 | U = 4.0, p = 0.026 |
| Percentage of CYBOCS improvement (mean ± SD) | 8.6 ± 9.1 | 50.5 ± 2.1 | U = 36.0, p = 0.002 |